Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)

Background
The Stephen I. Katz Early Stage Investigator Research Project Grant is issued by the National Institutes of Health (NIH) under the Department of Health and Human Services. This grant aims to support innovative research projects that signify a change in research direction for early stage investigators (ESIs) who do not have preliminary data. The mission of NIH is to seek fundamental knowledge about living systems and apply that knowledge to improve health.

Grant Details
The grant supports innovative projects representing a change in research direction for ESIs without preliminary data. Applications must include a separate attachment detailing this change. Proposed projects should align with the scientific missions of participating NIH Institutes and Centers and must not involve clinical trials. The application must describe how the proposed research differs from prior work, emphasizing innovation and uniqueness. Applications including preliminary data will be deemed noncompliant and withdrawn.

Eligibility Requirements
Eligible applicants include higher education institutions, nonprofits, for-profit organizations, local and state governments, tribal governments, and other entities as specified. All Principal Investigators (PIs) must be designated as ESIs by NIH.

Period of Performance
The maximum project period is 5 years, with specific timelines for application submission and award cycles outlined in the grant announcement.

Grant Value
Application budgets are not limited but should reflect the actual needs of the proposed project. The number of awards is contingent upon NIH appropriations and the submission of meritorious applications.